Related Experiment Videos
Erythropoietin, an update, and where to in the future?
1General University Hospital, Department of Medicine, Prague, Czech Republic.
EDTNA/ERCA Journal (English Ed.)
|July 7, 1999
Abstract:
Recombinant human erythropoietin has been produced by genetic technology since 1985 and since then many clinical trials have repeatedly demonstrated its success in the correction of anaemia associated with renal failure. This paper discusses basic principles for its administration, potential side effects and strategies for non response to erythropoietin (Epo) therapy.